MAPT and Creutzfeldt Jacob disease: Finally, compared to a study by Kovacs et al. [9] that focused on tau pathology in CJD and identified 69.3% of cases with prominent tau co-pathology and an additional 16.0% of cases with discrete non-significant tau-immunoreactive neurites, our percentage (11.16%) of “pure” cases was surprisingly low.